Homenewsabout usContact UsWebsite
Welcome to the
Cipla Press Office
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support.
Follow us:

Latest news

David Grier already halfway and might be first person to run The Great Wall of China in both directionsExtreme explorer, Cipla Foundation trustee and ambassador David Grier and fellow extreme athlete Andrew Stuart have passed the halfway mark of their gruelling 70-day, 4,200-kilometre journey across the Great Wall of China. 21 May 2018 Read more

South Africans urged to have their blood pressure tested regularlyGlobally, it is estimated that approximately 7.5 million people die annually from complications due to high blood pressure (also known as hypertension). The Heart and Stroke Foundation of South Africa estimates that more than one in every three South African adults is currently living with hypertension, a condition that is responsible for as much as 50% of reported strokes and 40% of heart attacks. 21 May 2018 Read more

Educating children about asthma is the best way to manage symptomsSouth Africa has the highest asthma death rate in the world - according to the World Health Organisation's (WHO) Detailed Mortality Database - and globally 334 million people are estimated to suffer from asthma.1 2 May 2018 Read more

World Primary Immunodeficiency Week 22-29 April 2018'My future starts with early testing and diagnosis of Primary Immunodeficiency' 30 Apr 2018 Read more

Cipla Foundation's David Grier takes on the Great Wall of China - againExtreme explorer, Cipla Foundation trustee and ambassador, David Grier, embarked on 28 March 2018 to run the full length of the Great Wall of China - a feat he already completed in 2006 when he became one of the first people in history to run the 4,200km distance in 93 days. Now, nearly 12 years later, Grier has returned to China to run the wall in the opposite direction. 10 Apr 2018 Read more

More news...

Contact Cipla

Tel: +27 21 943 4200
Customer Care: 080 222 6662